<DOC>
	<DOCNO>NCT02905552</DOCNO>
	<brief_summary>Myelodysplastic Syndromes ( MDS ) characterize quantitative qualitative bone marrow failure disorder medullary production pre-leukemic state evolve acute myeloid leukemia . The risk leukemic transformation estimate score IPSS ( International Prognostic Score System ) . We distinguish MDS low risk ( IPSS &lt; 1 ) high risk leukemic transformation ( IPSS=1,5 ) . Besides risk leukemic transformation , MDS much complicate infection could life-threatening . The risk develop first infection diagnosis MDS high risk probably influence anamnestic ( disease duration , comorbidities ) , clinical ( veinous central catheter , previous hospitalization ) , biological ( neutropenia , lymphopenia , serum ferritin ) therapeutic ( demethylating agent , lenalidomide , erythropoietin , G-CSF , transfusion , anti-infectious preventive treatment ) factor . Their identification allow improve target population likely benefit anti-infective prophylaxis Primary objective identify risk factor associate first acute episode infection patient MDS , compare index case match control case develop infection episode since diagnosis . Secondary objective explore nature severity infectious episode , number recurrence 1 year follow survival 6 12 month</brief_summary>
	<brief_title>Myelodysplasic Syndromes Risk Factors Infection</brief_title>
	<detailed_description>- 160 couple ( Case / Control ) - Pairing accord age ( +/- 5 year ) , sex medical consultation date ( +/-15 day ) - Follow M3 , M6 , M9 M12 - Study duration : 24 month - Inclusion duration : 12 month</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<criteria>Age &gt; 18 year old MDS IPSS &gt; 1.5 With first infectious episode since diagnosis SMD high risk ( Case ) Unhurt infection able mat case index ( Control ) Consulting hospitalize one service involve study period inclusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Myelodysplastic syndrome ( myelodysplasia )</keyword>
	<keyword>Infection</keyword>
	<keyword>Risk Factors</keyword>
</DOC>